Long-term trends and COVID-19 pandemic–era changes in the incidence of cancers with established screening strategies in the United States: a population-based SEER study

Abstract Cancer screening and prevention constitute essential components of cancer control, although their influence on population-level incidence varies across cancer types and is shaped by patterns of healthcare access and utilization. Large-scale public health emergencies can disrupt the delivery of routine preventive, diagnostic, and oncologic services. The present study examines long-term incidence trends and evaluates changes in cancer incidence patterns during the COVID-19 pandemic. Data were sourced from the Surveillance, Epidemiology, and End Results (SEER) 21 registries database. Age-adjusted incidence rates for lung and bronchus, colon and rectum, breast, and cervix uteri cancers among adults aged 40 years and older were analyzed separately from 2000 to 2022. Joinpoint regression analysis was conducted to assess long-term incidence trends. Pre-pandemic trends from 2000 to 2019 were extrapolated to estimate expected incidence rates for 2020–2022, which were compared with observed rates. Long-term incidence declined significantly for lung and bronchus (AAPC, − 1.81%), colorectal (AAPC, − 1.94%), and cervical cancers (AAPC, − 1.48%) from 2000 to 2022, whereas breast cancer incidence showed no significant overall change (AAPC, − 0.32%). Descriptive subgroup analyses demonstrated heterogeneous patterns across age, sex, race/ethnicity, and stage. Stage distribution among diagnosed cases showed only modest year-to-year variation across the four cancer sites. Over the past two decades, lung and bronchus, colorectal, and cervical cancer incidence declined, whereas breast cancer incidence remained relatively stable among adults aged ≥ 40 years. During 2020–2022, observed incidence rates for several cancer types deviated from those expected based on pre-pandemic trends, with the largest reductions generally observed in 2020 and variable patterns thereafter. These findings highlight the importance of maintaining accessible and resilient cancer screening and diagnostic services during future public health emergencies to minimize potential disruptions in timely cancer detection and care.

Authors

Publication Details

Journal
Scientific Reports
Published
2026-11-15
DOI
https://doi.org/10.1038/s41598-026-77995-4
Primary Topic
Global Cancer Incidence and Screening
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Long-term trends and COVID-19 pandemic–era changes in the incidence of cancers with established screening strategies in the United States: a population-based SEER study

Afnan W.M. Jobran, Bahaa Mali, Mohammed Abdulrazzak, A. B. Mali et al.
Scientific Reports
Global Cancer Incidence and Screening
article

Long-term trends and COVID-19 pandemic–era changes in the incidence of cancers with established screening strategies in the United States: a population-based SEER study

Afnan W.M. Jobran, Bahaa Mali, Mohammed Abdulrazzak, A. B. Mali, Ali Mali
article en

Abstract

Abstract Cancer screening and prevention constitute essential components of cancer control, although their influence on population-level incidence varies across cancer types and is shaped by patterns of healthcare access and utilization. Large-scale public health emergencies can disrupt the delivery of routine preventive, diagnostic, and oncologic services. The present study examines long-term incidence trends and evaluates changes in cancer incidence patterns during the COVID-19 pandemic. Data were sourced from the Surveillance, Epidemiology, and End Results (SEER) 21 registries database. Age-adjusted incidence rates for lung and bronchus, colon and rectum, breast, and cervix uteri cancers among adults aged 40 years and older were analyzed separately from 2000 to 2022. Joinpoint regression analysis was conducted to assess long-term incidence trends. Pre-pandemic trends from 2000 to 2019 were extrapolated to estimate expected incidence rates for 2020–2022, which were compared with observed rates. Long-term incidence declined significantly for lung and bronchus (AAPC, − 1.81%), colorectal (AAPC, − 1.94%), and cervical cancers (AAPC, − 1.48%) from 2000 to 2022, whereas breast cancer incidence showed no significant overall change (AAPC, − 0.32%). Descriptive subgroup analyses demonstrated heterogeneous patterns across age, sex, race/ethnicity, and stage. Stage distribution among diagnosed cases showed only modest year-to-year variation across the four cancer sites. Over the past two decades, lung and bronchus, colorectal, and cervical cancer incidence declined, whereas breast cancer incidence remained relatively stable among adults aged ≥ 40 years. During 2020–2022, observed incidence rates for several cancer types deviated from those expected based on pre-pandemic trends, with the largest reductions generally observed in 2020 and variable patterns thereafter. These findings highlight the importance of maintaining accessible and resilient cancer screening and diagnostic services during future public health emergencies to minimize potential disruptions in timely cancer detection and care.

Scientific Reports
Global Cancer Incidence and Screening
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon